Concepedia

Mark L. Behnke

ML

20

Publications

2.1K

Citations

17

H-Index

1983

Active since

Affiliations

National Center for Advancing Translational Sciences(Current)

Boehringer Ingelheim (Japan)

Boehringer Ingelheim (Brazil)

South Texas Veterans Health Care System

Women's Health Research Institute

Mark L. Behnke is an author at National Center for Advancing Translational Sciences specializing in drug discovery, pharmacology, and medicine.

Top concepts

Publications per year

1983–2018

20

Publications

20

Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids

Julian Adams, Mark L. Behnke, Shaowu Chen et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 680 citations · Full text

, , +8

Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)

Martin Tremblay, André Lescarbeau, Michael J. Grogan et al. · Journal of Medicinal Chemistry · 2009 · 250 citations · Full text

, , +13

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones

Karl D. Hargrave, John Proudfoot, Karl Grozinger et al. · Journal of Medicinal Chemistry · 1991 · 208 citations · Full text

, , +16

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones

Janice M. Klunder, Karl D. Hargrave, M. L. WEST et al. · Journal of Medicinal Chemistry · 1992 · 143 citations · Full text

A general allylation procedure using trimethylallylsilane and fluoride catalysis

George Majetich, Ada M. Casares, David Chapman et al. · The Journal of Organic Chemistry · 1986 · 116 citations

, , +13

Rows per page

1–5 of 20